How GlaxoSmithKline Suppressed Data on Paxil-Induced Akathisia: Implications for Suicidality and Violence

Since the publication of my first special report concerning how the manufacturer of Paxil hid and manipulated data concerning Paxil-induced suicide, in May 2006 the drug company GlaxoSmithKline issued a letter to Healthcare Providers confirming that depressed adults of all ages taking the antidepressant have an increased rate of suicidality compared to depressed adults taking placebo. This special report is the second in a series demonstrating that GlaxoSmithKline hid or manipulated data that years ago indicated that Paxil increases the risk of suicidality and other dangerous adverse mental effects of the drug.

Download report here - PDF Format:
http://www.breggin.com/Peter%20Breggins%20Paxil%20Special%20Report%20II.pdf